These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1268026)

  • 1. Letter: Blood levels of 5-fluorouracil during intravenous infusion.
    Kawai M; Rosenfeld J; McCulloch P; Hillcoat BL
    Br J Cancer; 1976 Mar; 33(3):346-7. PubMed ID: 1268026
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion.
    Hillcoat BL; McCulloch PB; Figueredo AT; Ehsan MH; Rosenfeld JM
    Br J Cancer; 1978 Dec; 38(6):719-24. PubMed ID: 743489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of marrow toxicity in patients treated by intravenous infusion of 5 fluorouracil.
    Hillcoat BL; Banerjee M; McCulloch PB; Williams CK
    Eur J Cancer (1965); 1977 Jan; 13(1):81-7. PubMed ID: 844477
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical pharmacological studies on 5-FU treatment for advanced gastro-intestinal carcinomas.
    Carcassonne Y; Seitz JF; Cano JP
    Bull Cancer; 1979; 66(1):97-100. PubMed ID: 420954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of 5-fluorouracil in plasma by GC/MS using an internal standard. Applications to pharmacokinetics.
    Cano JP; Rigault JP; Aubert C; Carcassonne Y; Seitz JF
    Bull Cancer; 1979; 66(1):67-74. PubMed ID: 420949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal chemotherapy for malignant diseases of the gastrointestinal tract.
    Markman M
    Surg Gynecol Obstet; 1987 Jan; 164(1):89-93. PubMed ID: 3541260
    [No Abstract]   [Full Text] [Related]  

  • 7. The administration of 5-fluorouracil by mouth.
    Bruckner HW; Creasey WA
    Cancer; 1974 Jan; 33(1):14-8. PubMed ID: 4810089
    [No Abstract]   [Full Text] [Related]  

  • 8. Protracted ambulatory venous infusion of 5-fluorouracil.
    Lokich J; Fine N; Perri J; Bothe A
    Am J Clin Oncol; 1983 Feb; 6(1):103-7. PubMed ID: 6837501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infusional 5-fluorouracil in the treatment of gastrointestinal cancers: The Royal Marsden Hospital experience.
    Ross PJ; Webb A; Cunningham D; Prendiville J; Norman AR; Oates J
    J Infus Chemother; 1996; 6(3):141-4. PubMed ID: 9229326
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Fluorouracil in the treatment of gastrointestinal neoplasia.
    N Engl J Med; 1973 Apr; 288(17):910-2. PubMed ID: 4571248
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of continuous intravenous 5-fluorouracil therapy in 27 patients with neoplasms of the digestive tract].
    Pilone A; Delprete S; Pierangeli S; Frosini G; Pezzoli M
    G Ital Chemioter; 1984; 31(3):249-52. PubMed ID: 6085574
    [No Abstract]   [Full Text] [Related]  

  • 12. A rapid high-performance liquid chromatographic method for quantitation of 5-fluorouracil in plasma after continuous intravenous infusion.
    Sampson DC; Fox RM; Tattersall MH; Hensley WJ
    Ann Clin Biochem; 1982 Mar; 19(Pt 2):125-8. PubMed ID: 7073215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allopurinol modulation of high-dose fluorouracil toxicity.
    Fox RM; Woods RL; Tattersall MH; Brodie GM
    Lancet; 1979 Mar; 1(8117):677. PubMed ID: 85922
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-day iv infusion with 5-fluorouracil (5-FU; NSC-19893) for gastroenteric carcinoma after failure on weekly 5-FU therapy.
    Hum GJ; Bateman JR
    Cancer Chemother Rep; 1975; 59(6):1171-9. PubMed ID: 769960
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-Fluorouracil in the treatment of gastrointestinal neoplasia.
    Kaufman S
    N Engl J Med; 1973 Jan; 288(4):199-201. PubMed ID: 4264581
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of 5-fluorouracil administered by slow infusion and rapid injection.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Dec; 32(12):2717-9. PubMed ID: 4566290
    [No Abstract]   [Full Text] [Related]  

  • 17. [5-fluorouracil effectiveness and toxicity in the treatment of digestive trac.t neoplasms as a function of the mode of administration].
    Zelechowska JA; Madej G
    Nowotwory; 1976; 26(1):29-36. PubMed ID: 1257062
    [No Abstract]   [Full Text] [Related]  

  • 18. The rationale behind intraperitoneal chemotherapy in gastrointestinal malignancies.
    Speyer JL
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):23-8. PubMed ID: 4048973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of regional portal infusion of 5-fluorouracil in patients with primary and secondary liver cancer.
    Almersjo O; Gustavsson B; Hafström L
    Ann Chir Gynaecol Suppl; 1976; 65(1):27-32. PubMed ID: 1267405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancer.
    Reichman B; Markman M; Hakes T; Kemeny N; Kelsen D; Hoskins W; Rubin S; Lewis JL
    J Clin Oncol; 1988 Jan; 6(1):158-62. PubMed ID: 3335888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.